Hel Ved Capital Management Ltd bought a new position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 25,280 shares of the company's stock, valued at approximately $2,274,000.
Other institutional investors and hedge funds have also modified their holdings of the company. Resona Asset Management Co. Ltd. bought a new stake in shares of DocuSign in the 4th quarter valued at approximately $5,412,000. Wells Fargo & Company MN lifted its stake in shares of DocuSign by 15.9% in the fourth quarter. Wells Fargo & Company MN now owns 377,439 shares of the company's stock worth $33,947,000 after buying an additional 51,789 shares during the last quarter. Pinpoint Asset Management Ltd acquired a new stake in shares of DocuSign in the fourth quarter valued at about $3,323,000. Landscape Capital Management L.L.C. bought a new position in shares of DocuSign in the fourth quarter worth about $2,294,000. Finally, Motley Fool Asset Management LLC lifted its position in shares of DocuSign by 17.7% during the 4th quarter. Motley Fool Asset Management LLC now owns 4,880 shares of the company's stock worth $439,000 after purchasing an additional 733 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.
Insider Activity at DocuSign
In other DocuSign news, CFO Blake Jeffrey Grayson sold 8,000 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $86.90, for a total value of $695,200.00. Following the sale, the chief financial officer now owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider James P. Shaughnessy sold 7,500 shares of the firm's stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total transaction of $609,825.00. Following the transaction, the insider now directly owns 45,875 shares of the company's stock, valued at $3,730,096.25. This represents a 14.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 57,851 shares of company stock worth $4,911,319. 1.66% of the stock is owned by company insiders.
DocuSign Stock Performance
NASDAQ:DOCU traded down $6.19 on Thursday, hitting $72.40. 815,365 shares of the stock were exchanged, compared to its average volume of 2,476,699. The company's 50-day moving average price is $83.86 and its 200 day moving average price is $82.56. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The stock has a market capitalization of $14.66 billion, a price-to-earnings ratio of 14.92, a P/E/G ratio of 6.94 and a beta of 1.20.
DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. The firm had revenue of $776.25 million during the quarter, compared to analysts' expectations of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business's revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.76 earnings per share. As a group, equities research analysts predict that DocuSign, Inc. will post 1.17 earnings per share for the current year.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Citigroup increased their price objective on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research report on Friday, March 14th. Wedbush restated a "neutral" rating and set a $100.00 price target on shares of DocuSign in a research note on Friday, March 14th. JMP Securities reissued a "market outperform" rating and set a $124.00 price objective on shares of DocuSign in a report on Tuesday, January 7th. Wells Fargo & Company boosted their price objective on DocuSign from $70.00 to $73.00 and gave the company an "underweight" rating in a research report on Friday, March 14th. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $90.00 price target on shares of DocuSign in a report on Friday, March 14th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, DocuSign has an average rating of "Hold" and a consensus target price of $95.83.
Read Our Latest Report on DocuSign
About DocuSign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.